Skip to main content
Item(s) Added to Cart

0 item(s) Subtotal $0,00

Anti-Obesity Medication Webinar Series

Anti-Obesity Medications: An Interdisciplinary Panel Discusses Cases

Join us June 4 for the third and final installment of our webinar series covering anti-obesity medications. This webinar series is made possible through a sponsorship from Eli Lilly and is supported by an educational grant provided by Novo Nordisk Inc. to the Academy Foundation.

Member Price $0.00

Nonmember Price $0.00

Details

Date: June 4
Time: noon-1:30 p.m. (Central time)

The newer second-generation obesity medications, also referred to as incretin-based therapies, are yielding weight losses beyond what has typically been achieved with lifestyle interventions alone, including assisting in the management or prevention of obesity-related diseases. These benefits are making the use of these medications extremely popular among an array of people with overweight or obesity. These medications are being prescribed by a wide gamut of healthcare providers with prescriptive authority, from primary care providers with minimal obesity expertise to those with extensive expertise in obesity management.

This third webinar aims to apply knowledge gained from webinars one and two, with an interdisciplinary panel of obesity experts including a pharmacist, physician, family nurse practitioner and an RDN. These experts will present several common clinical scenarios they observe in their varied practices and offer practical management strategies in a discussion format. These presenters will focus the case scenarios to the roles of the RDN with obesity medications and nutrition management to achieve positive clinical outcomes. This interdisciplinary panel of presenters will each offer attendees key points for RDNs.

This webinar does not provide CPE credit. The recording will be posted to eatrightPRO following the event.

Learning Objectives

  • Apply knowledge gained from webinar #1 and #2 in this series to interdisciplinary discussion of real-world cases.
  • Discuss distinct presentations of individuals using obesity medications in clinical practice, along with corresponding strategies for successful management.
  • List ways to work productively with interdisciplinary healthcare providers partners to achieve positive clinical outcomes for individuals using these medications.
  • Identify tactics to promote referrals to RDNs for MNT for individuals taking obesity medications.

Speakers

Dan Bessesen, MD

Dan is Professor of Medicine in the Division of Endocrinology at the University of Colorado, School of Medicine (UC-SOM) and has worked at Denver Health Medical Center for nearly 30 years. He's been the Executive Director of the Anschutz Health and Wellness Center at UC-SOM since 2019. Over the last 30 years his research group has been involved in studies of the regulation of body weight. Dan has also been involved in studies of obesity management in primary care and in medical education for much of his career. He currently is the Program Director for the new Obesity Medicine Fellowship Program in Colorado. Lastly, Dan serves as faculty for the Commission on Dietetic Registration (CDR)'s Obesity Certificate Training Program (CSOWM).

Colleen Dawkins, FNP, RDN, CSOWM,

Colleen is board-certified as a Family Nurse Practitioner, a Registered Dietitian Nutritionist, and holds the CSOWM credential. She owns and operates a private practice at Big Sky Medical Wellness based in Big Sky, Mont., where she delivers care mainly virtually. Colleen holds numerous volunteer positions that focus on obesity including as secretary for the Washington Obesity Society, vice chair for CDR's Obesity Certificate Training Program, and a member of the Obesity Medicine Association's algorithm committee. Colleen is an associate editor for the Obesity Pillars journal, a member of an international research collaboration, and an item writer for the AANP Board Certification exam. Colleen is currently a doctoral student in nursing leadership.

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP

Diana is an Endocrinology Clinical Pharmacy Specialist at Cleveland Clinic. She holds board certifications in pharmacotherapy, ambulatory care, and advanced diabetes management. She served on the American Diabetes Association (ADA) Professional Practice Committee from 2020-2023, helping to update their Standards of Medical Care for Diabetes. Diana advocates access and choice to the latest technologies and therapeutics for people with diabetes and overweight/obesity and speaks on these topics internationally. She was the ADCES Diabetes Care and Education Specialist of the Year in 2020 and inducted into the Southern Illinois University Edwardsville Hall of Fame in 2022 for her far reaching contributions in cardiometabolic care.

Amy von Sydow Green, MD, MS, RD

Amy is a clinical dietitian at Penn Metabolic Medicine, a clinic that specializes in medical weight management within the University of Pennsylvania Health System. Amy provides Medical Nutrition Therapy for people with obesity and/or type 2 diabetes and has been counseling people being treated with obesity medications since 2015. Over the past few years Amy has shared her expertise and knowledge in medical weight management and nutrition counseling with her RDN colleagues at FNCE and other conferences. Prior to receiving her Master of Science Degree in Human Nutrition from Drexel University (Philadelphia, Penn.) she received a Medical Degree from the Sahlgrenska Academy in Gothenburg, Sweden where she practiced medicine before moving to the U.S.

Moderator

Hope Warshaw, MMSc, RD, CDCES, BC-ADM, co-coordinator of this 3-part webinar series.

Release Date: June 4, 2024

Check Out Our Current Sales

From seasonal specials celebrating commemorative events and awareness campaigns to sales on soon-to-expire CPE activities and book titles for which new editions are just around the corner, don't miss this opportunity to grab cutting-edge resources at discounted prices.